Prazosin Market Share, Trends, Size, Research and Forecast 2020-2026

 

The global prazosin market is estimated to exhibit a negative CAGR of around 2% during the forecast period. Though the rise in CVDs due to high BP, increasing patient pool, and increasing awareness toward mental care are some of the positive factors for the growth of the market. However, due to the presence of alternative drugs, discontinuation of prazosin manufacturing by companies in the last decade, unfavorable reimbursement policies for the branded drug in medical insurance, and side effects associated with the drugs, the market is expected to show a negative growth rate during the forecast period.

The global prazosin market is segmented on the basis of its application into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. It is majorly used for cardiovascular disease that is used to relieve hypertension/high BP due to which it will hold the largest market share.

A full report of Global Prazosin Market is available at:  https://www.omrglobal.com/industry-reports/prazosin-market

Geographically, the study of the global prazosin market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. North America is expected to hold the largest market share during the forecast period. The high cost of drugs, significant sale of branded drugs of Pfizer in the region is major factors for the largest market, globally. In October 2018, Novitium Pharma LLC received the US FDA approval for its Prazosin Hydrochloride Capsules USP which is also providing significant market share in the region.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/prazosin-market

The companies which are contributing to the growth of the global prazosin market include Pfizer Inc., Mylan N.V., Merk KGaA, Teva Pharmaceuticals Industries Ltd., Apotex Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launch, merger, and acquisition to stay competitive in the market. In November 2019, Pfizer Inc., and Mylan NV announced to form a new company named Viatris by merging Mylan and Upjohn division of Pfizer. The deals were expected to be closed by mid of 2020, however, due to the COVID-19 pandemic, the deal is expected to close by the end of 2020.

Global Prazosin Market- Segmentation

By Application

• Cardiovascular Disease(CVD)
• Neurological Syndromes 
• Prostate Disorders
• Kidney Disorders

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/prazosin-market

Global Prazosin Market– Segment by Region

North America          

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific   

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Ajinomoto Co., Inc.
• Apotex Inc.
• Axon Medchem LLC
• Cayman Chemical Co.
• Johnlee Pharmaceuticals Pvt. Ltd.
• Merck KGaA
• NovitiumPharma
• Pfizer Inc.
• R&D Systems Inc.
• Renata Ltd.
• Mylan N.V.
• Standard Chem and Pharmaceuticals Co. Ltd.
• Sun Pharmaceuticals Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.
• TRC Inc.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 7803040404